Scientific Highlights
Research articles:
2023 – Optical Spectrophotometry as a Promising Method for Quantification and Stage Differentiation of Plasmodium falciparum Parasites.
Baptista V, Silva M, Ferreira GM, Calçada C, Minas G, Veiga MI, Catarino SO.
ACS Infect Dis. 2023 Jan 13;9(1):140-149. doi: 10.1021/acsinfecdis.2c00484.
2022 – Plasmodium falciparum Drug Resistance Genes pfmdr1 and pfcrt In Vivo Co-Expression During Artemether-Lumefantrine Therapy.
Silva M, Malmberg M, Otienoburu SD, Björkman A, Ngasala B, Mårtensson A, Gil JP, Veiga MI.
Front Pharmacol. 2022 May 24;13:868723. doi: 10.3389/fphar.2022.868723.
2021 – The Future in Sensing Technologies for Malaria Surveillance: A Review of Hemozoin-Based Diagnosis.
Baptista V, Costa MS, Calçada C, Silva M, Gil JP, Veiga MI, Catarino SO.
ACS Sens. 2021 Nov 26;6(11):3898-3911. doi: 10.1021/acssensors.1c01750.
2021 – OmniSARS2: A Highly Sensitive and Specific RT-qPCR-Based COVID-19 Diagnostic Method Designed to Withstand SARS-CoV-2 Lineage Evolution.
Carvalho-Correia E, Calçada C, Branca F, Estévez-Gómez N, De Chiara L, Varela N, Gallego-García P, Posada D, Sousa H, Sousa J, Veiga MI*, Osório NS*.
Biomedicines. 2021 Sep 26;9(10):1314. doi: 10.3390/biomedicines9101314.
2020 – Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport.
Calçada C, Silva M, Baptista V, Thathy V, Silva-Pedrosa R, Granja D, Ferreira PE, Gil JP, Fidock DA, Veiga MI.
mBio. 2020 Dec 1;11(6):e02093-20. doi: 10.1128/mBio.02093-20.
2020 – Multigenic architecture of piperaquine resistance trait in Plasmodium falciparum.
Silva M, Calçada C, Teixeira M, Veiga MI, Ferreira PE.
Lancet Infect Dis. 2020 Jan;20(1):26-27. doi: 10.1016/S1473-3099(19)30689-9.
2019 – Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy.
Silva M, Ferreira PE, Otienoburu SD, Calçada C, Ngasala B, Björkman A, Mårtensson A, Gil JP, Veiga MI.
J Antimicrob Chemother. 2019 Jul 1;74(7):1890-1893. doi: 10.1093/jac/dkz098.
2017 – Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M, Lucantoni L, Li T, Combrinck JM, Ruecker A, Kumar TRS, Rubiano K, Ferreira PE, Siciliano G, Gulati S, Henrich PP, Ng CL, Murithi JM, Corey VC, Duffy S, Lieberman OJ, Veiga MI, Sinden RE, Alano P, Delves MJ, Lee Sim K, Winzeler EA, Egan TJ, Hoffman SL, Avery VM, Fidock DA.
Nat Microbiol. 2017 Oct;2(10):1403-1414. doi: 10.1038/s41564-017-0007-4.
2016 – Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies.
Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnädig N, Uhlemann AC, Martin RE, Lehane AM, Fidock DA.
Nat Commun. 2016 May 18;7:11553. doi: 10.1038/ncomms11553.
Patents:
2021 – WO2021191882 ANTIMALARIAL AGENT, METHODS AND USES THEREOF
2022 – WO2022070084 AUTOMATIC DEVICE FOR NON-INVASIVE MALARIA DIAGNOSIS THROUGH OPTICAL REFLECTANCE TECHNIQUES, METHODS AND USES THEREOF